Cargando…

Beta Cell Therapies for Preventing Type 1 Diabetes: From Bench to Bedside

Type 1 diabetes (T1D) is a chronic metabolic disease characterized by insulin deficiency, generally resulting from progressive autoimmune-mediated destruction of pancreatic beta cells. While the phenomenon of beta cell autoimmunity continues to be an active area of investigation, recent evidence sug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brawerman, Gabriel, Thompson, Peter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765619/ https://www.ncbi.nlm.nih.gov/pubmed/33339173 http://dx.doi.org/10.3390/biom10121681

Ejemplares similares

Research in Sickle Cell Disease: From Bedside to Bench to Bedside
por: Salinas Cisneros, Gabriel, et al.
Publicado: (2021)

CDG Therapies: From Bench to Bedside
por: Brasil, Sandra, et al.
Publicado: (2018)

Immunotherapy for the Prevention and Treatment of Type 1 Diabetes: Optimizing the path from bench to bedside
por: Bresson, Damien, et al.
Publicado: (2009)

Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Alpha cell dysfunction in type 1 diabetes is independent of a senescence program
por: Brawerman, Gabriel, et al.
Publicado: (2022)

RNA-based Gene Therapy for the Treatment and Prevention of HIV: From Bench to Bedside
por: Zeller, Skye J., et al.
Publicado: (2011)

Sepsis: From Bench to Bedside
por: Silva, Eliézer, et al.
Publicado: (2008)

Linagliptin: from bench to bedside
por: Doupis, John
Publicado: (2014)

Mesenchymal stromal cell therapy in COPD: from bench to bedside
por: Antunes, Mariana A, et al.
Publicado: (2017)

CAR-T cell therapy in ovarian cancer: from the bench to the bedside
por: Zhu, Xinxin, et al.
Publicado: (2017)

CAR-T Cell Therapy: From the Bench to the Bedside
por: Golubovskaya, Vita
Publicado: (2017)

From Pathogenesis to Therapy in Knee Osteoarthritis: Bench-to-Bedside
por: Rezuş, Elena, et al.
Publicado: (2021)

DNA damage to β cells in culture recapitulates features of senescent β cells that accumulate in type 1 diabetes
por: Brawerman, Gabriel, et al.
Publicado: (2022)

Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside
por: Siracusano, Gabriel, et al.
Publicado: (2020)

Olutasidenib: from bench to bedside
por: Venugopal, Sangeetha, et al.
Publicado: (2023)

Glucocorticoid therapy in respiratory illness: bench to bedside
por: Amratia, Dhruv Atool, et al.
Publicado: (2022)

Current Medical Therapy for Adenomyosis: From Bench to Bedside
por: Etrusco, Andrea, et al.
Publicado: (2023)

An Update on Translating Stem Cell Therapy for Stroke from Bench to Bedside
por: Dailey, Travis, et al.
Publicado: (2013)

Hematopoietic Stem Cell Gene Therapy for Cystinosis: From Bench-to-Bedside
por: Cherqui, Stephanie
Publicado: (2021)

MEK and the inhibitors: from bench to bedside
por: Akinleye, Akintunde, et al.
Publicado: (2013)

Variable ventilation from bench to bedside
por: Huhle, Robert, et al.
Publicado: (2016)

Biology of Cholangiocytes: From Bench to Bedside
por: Yoo, Kyo-Sang, et al.
Publicado: (2016)

Dystonia and Cerebellum: From Bench to Bedside
por: Morigaki, Ryoma, et al.
Publicado: (2021)

Alcohol in Psoriasis—From Bench to Bedside
por: Szentkereszty-Kovács, Zita, et al.
Publicado: (2021)

Pathomechanisms, therapeutic targets and potent inhibitors of some beta-coronaviruses from bench-to-bedside
por: Ayipo, Yusuf Oloruntoyin, et al.
Publicado: (2021)

From bench to bedside
por: Verdant, Colin L
Publicado: (2012)

Hydrogen sulfide therapy in brain diseases: from bench to bedside
por: Zhang, Ju-yi, et al.
Publicado: (2017)

Advancing stem cell therapy from bench to bedside: lessons from drug therapies
por: Srijaya, Thekkeparambil Chandrabose, et al.
Publicado: (2014)

Type 1 regulatory T (Tr1) cells: from the bench to the bedside
por: Gregori, Silvia, et al.
Publicado: (2012)

The NF1 gene revisited – from bench to bedside
por: Yap, Yoon-Sim, et al.
Publicado: (2014)

Lumasiran in the Management of Patients with Primary Hyperoxaluria Type 1: From Bench to Bedside
por: D’Ambrosio, Viola, et al.
Publicado: (2022)

Has retinal gene therapy come of age? From bench to bedside and back to bench
por: Trapani, Ivana, et al.
Publicado: (2019)

Cancer proteomics: from bench to bedside
por: Timms, J F
Publicado: (2008)

Indirect Calorimetry: From Bench to Bedside
por: Gupta, Riddhi Das, et al.
Publicado: (2017)

Drug addiction: from bench to bedside
por: Cheron, Julian, et al.
Publicado: (2021)

Bench and Bedside
por: Schmidt, Christian
Publicado: (2002)

Mast Cells in Cardiovascular Disease: From Bench to Bedside
por: Hermans, M. A. W., et al.
Publicado: (2019)

CAR-T cell therapy in gastrointestinal tumors and hepatic carcinoma: From bench to bedside
por: Zhang, Qi, et al.
Publicado: (2016)

Challenges and perspectives of tendon-derived cell therapy for tendinopathy: from bench to bedside
por: Chen, Ziming, et al.
Publicado: (2022)

Stem Cell Therapy for Bronchopulmonary Dysplasia: Bench to Bedside Translation
por: Ahn, So Yoon, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5ssa2f61raqbtcrskug9evi4kr